EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Novel Strategy to Produce CAR ‐γδ T Cells via Site‐Directed Gene Integration by a Combination of CRISPR /Cas9 and AAV

Ruoyu Dong, Yixi Zhang, Guangxun Yuan, Xiaoyan Yue, Yingying Ding, Xun Zeng iD, Haowen Xiao

Cancer Medicine · 2026

DOI: 10.1002/cam4.71918 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Ruoyu Dong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Cell Therapy, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China. Hauptthemen laut MEDLINE: Dependovirus, CRISPR-Cas Systems, Receptors, Chimeric Antigen, Receptors, Antigen, T-Cell, gamma-delta. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR)‐αβ T cells are commonly employed in tumor therapy but hindered by some limitations. γδ T cells are promising substrates for CAR therapy for their major histocompatibility complex (MHC)‐unrestricted recognition manner and innate immune function. Here, we established a novel method for generating CAR‐γδ T cells. We utilized the clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR‐associated protein 9 (Cas9) (CRISPR/Cas9) method to interrupt the TCR delta chain constant region ( TRDC ) sequence, followed by the site‐directed insertion of the CAR sequence into the TRDC locus via homologous complementation mediated by adeno‐associated virus (AAV) gene delivery. We optimized electroporation parameters for Cas9/ribonucleoproteins (RNP) delivery and infection conditions for CAR‐gene carrying AAV in γδ T cells. These optimizations facilitated efficient TCR knockout and site‐directed CAR insertion, ultimately yielding functional CAR‐γδ T cells. In vitro experiments demonstrated that these newly prepared CAR‐γδ T cells could stimulate cytokine production, kill tumor cells as well as exhibit robust proliferative potential and memory‐like phenotype. These state‐of‐the‐art CAR‐γδ T cells could reduce tumor burden and extend the survival period of tumor‐bearing mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusCRISPR-Cas SystemsReceptors, Chimeric AntigenReceptors, Antigen, T-Cell, gamma-deltaT-LymphocytesImmunotherapy, AdoptiveAnimalsHumansMiceGenetic VectorsCell Line, TumorElectroporationFemale

Stichwörter der Autor:innen

AAVCAR‐γδ T cellsCRISPR/Cas9TCR site‐specific knockoutelectroporationhematologic malignanciesknockin

Substanzen

Receptors, Chimeric AntigenReceptors, Antigen, T-Cell, gamma-delta

Autor:innen und Institutionen

  • Department of Hematology and Cell Therapy, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Di…
  • Department of Developmental Biology and Cancer, Great Ormond Street Institute of Child Health, University College London, London, UK.

ORCID-Profile: Xun Zeng

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Dong, R., Zhang, Y., Yuan, G., Yue, X., Ding, Y., Zeng, X., & Xiao, H. (2026). A Novel Strategy to Produce CAR ‐γδ T Cells via Site‐Directed Gene Integration by a Combination of CRISPR /Cas9 and AAV. Cancer Medicine. https://doi.org/10.1002/cam4.71918

Vancouver

Dong R, Zhang Y, Yuan G, Yue X, Ding Y, Zeng X, et al. A Novel Strategy to Produce CAR ‐γδ T Cells via Site‐Directed Gene Integration by a Combination of CRISPR /Cas9 and AAV. Cancer Medicine. 2026. doi:10.1002/cam4.71918

BibTeX
@article{Dong2026,
  author = {Dong, Ruoyu and Zhang, Yixi and Yuan, Guangxun and Yue, Xiaoyan and Ding, Yingying and Zeng, Xun and Xiao, Haowen},
  title = {A Novel Strategy to Produce CAR ‐γδ T Cells via Site‐Directed Gene Integration by a Combination of CRISPR /Cas9 and AAV},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.71918}
}
Kostenlos starten →